Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 701-720 of 2,731 trials

A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients

NCT02102256

Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear anatomical abnormalities, are limited and, in the case of absent cochleas, non-existent. An auditory brainstem implant (ABI) places an electrode close to the auditory nucleus in the brainstem. Children aged 2 - 5 who are not candidates for a cochlear implant, or who did not demonstrate benefit from a cochlear implant, will be implanted with an ABI and followed for 1 year for safety and a total of 3 years for preliminary efficacy. This is a feasibility study to determine the safety of the ABI.

Profound Bilateral Deafness Due toBilateral Cochlear AplasiaBilateral Cochlear Nerve Deficiency+1 more

Laurie Eisenberg10 participantsStarted Mar 2014

Los Angeles, California, United States • Los Angeles, California, United States

RECRUITINGPhase 3< 1 mile

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

NCT03678025

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more

SWOG Cancer Research Network1,273 participantsStarted Sep 2018

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +335 more locations

A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Rheumatoid Arthritis Trials in Other Cities

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Expanded Access Program for Revumenib

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

FebriDx® Method Comparison Study Protocol

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Animal Assisted Intervention With Dogs for Children With ADHD

OCS DCD Heart + CAP Continued Follow-Up

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Other Conditions in Los Angeles